NCT00632216View on ClinicalTrials.gov

A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis

PHASE4CompletedINTERVENTIONAL
Enrollment

464

Participants

Timeline

Start Date

May 31, 2004

Study Completion Date

May 31, 2006

Conditions
Osteoporosis, Postmenopausal
Interventions
DRUG

Risedronate Sodium

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT00632216 - A Study to Determine the Satisfaction With Actonel in Postmenopausal Women With Osteoporosis | Biotech Hunter | Biotech Hunter